ATC Group: R06AX26 Fexofenadine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AX26 in the ATC hierarchy

Level	Code	Title
`1`	R	Respiratory system
`2`	R06	Antihistamines for systemic use
`3`	R06A	Antihistamines for systemic use
`4`	R06AX	Other antihistamines for systemic use
`5`	R06AX26	Fexofenadine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	120 mg

Active ingredients in R06AX26

Active Ingredient
Fexofenadine
Fexofenadine is a non-sedating H₁ antihistamine. Fexofenadine is a pharmacologically active metabolite of terfenadine.

Related product monographs

Document	Type	Information Source
ALLEGRA ALLERGY Film coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
FEXOFAST Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
TELFAST Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)